×

Stocks Anthem Inc

  • FED_RESERVE3.jpg

    What the Fed will say in its Tuesday statement is at the heart of a debate among Wall Street's deeply-divided economists over what steps, if any, the central bank will take.

  • Fears about this company are overblown, Cramer said. Here's why you should stick with it.

  • With Tony Hayward leaving the top spot at BP, Cramer's marquee list of who he thinks are the worst bosses in business needed an update.

    Find some of their most debatable choices in this slide show—and Cramer's opinion on them, of course—which includes the CEOs of Nokia, Johnson & Johnson, Massey Energy, Blackstone Group, WellPoint and more.

  • Cramer wants your nominations for the Mad Money Wall of Shame.

  • Chief executives at a companies in industries ranging from hotels, to energy, to health care, to technology, and restaurants, have a wide-range views on where the economy is now and where it's going.

  • earnings_central_badge.jpg

    What follows is a roundup of corporate earnings reports for Wednesday, July 28.

  • Stocks skidded Thursday, led by financials after JPMorgan's earnings failed to impress analysts and a pair of weak manufacturing reports.

  • Stocks trimmed some of its earlier losses but remained lower Thursday, led by financials, following a pair of tepid manufacturing reports that overshadowed strong earnings results from JPMorgan.

  • If investors want to return value to shareholders, Cramer says, they should increase their dividends.

  • Following a poor quarterly performance for most of the major averages, investors seeking opportunities for the rest of the year may want to look at companies with the potential to weather any potential "double dips". One of the metrics that is closely watched by Wall Street is the amount of cash available. 

  • Doctor talking to female patient in office

    Some of the nation’s insurers are now trying to avoid high medical costs by taking the longer view. They are giving primary care doctors more help — and more money — to take care of the sickest patients and help prevent them from becoming sicker. The NYT reports.

  • Drill ship recovering oil from the ruptured British Petroleum oil well over the site in the Gulf of Mexico off the coast of Louisiana.

    The drill ban could jeopardize 50,000 jobs, according to one estimate, hurting many blue-collar communities on the Gulf Coast. The NYT reports.

  • Stocks ended mostly higher after a late rally Tuesday as banks and materials rebounded. But tech stocks remained under pressure.

  • Stocks staged a late rally Tuesday as energy stocks made a comeback. But tech stocks fell after several downgrades.

  • Crisis_In_The_Gulf_badge.jpg

    Stocks ended the week in correction territory after a sharp selloff Friday as a disappointing jobs report and another possible debt crisis in Hungary intensified fears about the stability of the recovery.

  • Trading has been bullish in WellPoint Health Networks and Health Net since early Friday morning, as the rumor mill goes into overdrive. Both health insurers are up in an ugly tape, though the option activity is much greater in WellPoint.

  • The Lightning Round is extended in this CNBC.com exclusive feature.

  • Warren Buffett

    Warren Buffett latest SEC filings to the SEC show that those that say he's an investment dinosaur simply don't understand how the mind of the Omaha Oracle works. Truth is, he is so much more of a tactical investor than many people realize and there are lessons to be learned from his latest investment decisions.

  • 100517_whats_buffett_SELLIN.jpg

    Warren Buffett's Berkshire Hathaway sold a lot of stock during the first three months of the year, including a reduction of over 31 million shares for its stake in Kraft Foods spacer. That sale follows his outspoken criticism of Kraft and its management for acquiring Cadbury's.  Berkshire has also been raising money to pay for its now-completed $26 billion acquisition of the freight railroad Berkshire Hathaway Santa Fe.

  • marijuana_medical_200.jpg

    Marijuana is now legal for medical purposes in over a dozen states. But paying for it as a medical expense is still a non-starter.